Firm Profile
Portfolio
Offices
News
Contact_Us
Investor Login
Search
PORTFOLIO

ZymoGenetics

Stage: Spin-outs

Date of Investment: 2000

Web Site : http://www.zymogenetics.com

Stock Symbol : Nasdaq: ZGEN

ZymoGenetics, Inc., based in Seattle, WA, is a biopharmaceutical company focused on the development and commercialization of protein therapeutics. The Company launched its first drug on the US market in 2008, and has a strong pipeline of additional product candidates in development with meaningful commercial potential.

Warburg Pincus has been a significant investor in ZymoGenetics since 2000, when the firm led the spinout of Zymo from Novo Nordisk A/S, a major pharmaceutical company based in Denmark.

Back to Previous Page

© 2010 Warburg Pincus LLC. All rights reserved. Legal Disclaimer | Contact Us